Launch of Life Saving Wearable Cardioverter Defibrillator
Asahi Kasei ZOLL Medical (AZM) has announced the launch of LifeVest® cardioverter defibrillator in Japan. The service offering has started throughout Japan yesterday, April 15th. The service is designed to overcome sudden cardiac death (SCD) cause of death for approximately 60,000 people per year in Japan. LifeVest provides protection for individuals who are risk of SCD by constantly monitoring the patient’s heart. In an event where a life threatening heart rhythm (ventricular fibrillation or ventricular tachycardia) is detected the LifeVest delivers a treatment shock in order to restore the normal heart rhythm. The LifeVest is designed to protect a wide range of patients, including patients with newly diagnosed heart failure, following recent myocardial infraction, or following coronary revascularization.
The LifeVest comes with two sets of electrodes, one to measure electrocardiogram (ECG) and the other to deliver the treatment shock, all done automatically. The LifeVest can be rented from AZM to medical institutions and each patient rents the LifeVest from a medical institution based on a physician’s prescription using them while in hospital or at the comfort of home. AZM in turns provides a full range of support services to medical institutions, including education and training on use of the LifeVest, as well as maintenance and repair services and patient data management systems.